- Home
- / Intercept Pharmaceuticals
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Intercept Pharmaceuticals financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$19
2023-11-14
Market Capitalization
$794.7 M
2023-11-14
Revenue
$285.7 M
FY, 2022
CreditSafe Score
?
Score changed on Jun 06, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2012 | FY, 2013 | FY, 2014 | FY, 2015 | FY, 2016 | FY, 2017 | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 2.4M | 1.6M | 1.7M | 2.8M | 25.0M | 131.0M | 179.8M | 252.0M | 312.7M | 363.5M | 285.7M |
| Cost of goods sold | 1.4M | 2.5M | 4.2M | 5.3M | 3.1M | 984.0K | |||||
| Gross profit | 129.6M | 177.3M | 247.8M | 307.4M | 284.7M | ||||||
| Gross profit margin, % | 99.0% | 98.6% | 98.3% | 98.3% | 99.7% | ||||||
| General and administrative expense | 5.2M | 13.1M | 34.6M | 103.7M | 273.6M | 273.7M | 255.5M | 317.4M | 332.5M | 230.9M | 176.3M |
| Operating expense total | 21.4M | 41.2M | 115.7M | 234.7M | 427.5M | 465.2M | 462.8M | 560.2M | 538.6M | 416.0M | 352.9M |
| EBIT | (402.5M) | (335.6M) | (285.5M) | (312.4M) | (231.2M) | (55.7M) | (68.2M) | ||||
| EBIT margin, % | -1613.3% | -256.3% | -158.8% | -124.0% | -74.0% | -23.9% | |||||
| Interest expense | 4.2K | 28.3M | 170.1M | 2.7M | 10.3M | 24.8M | 23.8M | 32.3M | |||
| Pre tax profit | (226.4M) | (412.8M) | (360.4M) | (309.2M) | (344.7M) | (274.9M) | (91.4M) | (174.9M) | |||
| Net Income | (43.6M) | (67.8M) | (283.2M) | (226.4M) | (412.8M) | (360.4M) | (309.2M) | (344.7M) | (274.9M) | (91.4M) | 221.8M |
| EPS | 6.6 |